Lower and Lower It Goes | GenomeWeb

Obstacles to cheaper and cheaper sequencing are falling by the wayside, writes Eilene Zimmerman at CNN Money. She notes that when James Watson had his genome sequenced by 454 in 2007, it cost about $1 million, but newer technologies are bringing that cost drastically down.

"The cost-per-bit of biologic information is coming down faster than Moore's Law," Steven Burrill, from the financial services firm Burrill & Company tells her.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.